Literature DB >> 16299026

Polymorphisms in the T cell regulatory gene cytotoxic T lymphocyte antigen 4 influence the rate of acute rejection after liver transplantation.

O Tapirdamaz1, V Pravica, H J Metselaar, B Hansen, L Moons, J B J van Meurs, I V Hutchinson, J Shaw, K Agarwal, D H Adams, C P Day, J Kwekkeboom.   

Abstract

BACKGROUND: The cytotoxic T lymphocyte antigen 4 (CTLA-4) gene encodes for a membrane bound (mCTLA-4) and a soluble (sCTLA-4) isoform, which are both involved in regulation of T cell function. The CTLA-4 +49A/G single nucleotide polymorphism (SNP) influences expression of mCTLA-4; +6230G/A SNP affects the production of sCTLA-4. AIM: To examine whether these functional SNPs influence the rate of rejection after liver transplantation. PATIENTS AND METHODS: Liver graft recipients (n = 483) were genotyped for both SNPs, and haplotypes were reconstructed. Association with rejection was tested by the log rank test using the Kaplan-Meier method with time to the first acute rejection episode as outcome. Multiple analysis of SNPs together with demographic factors was performed by Cox regression.
RESULTS: Three haplotypes were observed in the cohort: +49A/+6230A, +49A/+6230G, and +49G/+6230G. The +49A/+6230G haplotype was significantly and dose dependently associated with acute rejection (p = 0.01). Of the demographic factors tested, only underlying liver disease was significantly associated with rejection. Adjusted for underlying liver disease, each additional +49A/+6230G haplotype allele resulted in a significantly higher risk of acute rejection (risk ratio 1.34 (95% confidence interval 1.04-1.72); p = 0.02). Patients who lacked this haplotype had the lowest, carriers an intermediate, and homozygotes the highest risk of acute rejection.
CONCLUSION: The CTLA-4 +49A/+6230G haplotype, which encodes for normal mCTLA-4 expression but reduced sCTLA-4 production, is a co-dominant risk allele for acute rejection after clinical liver transplantation. This implies that even under immunosuppression, CTLA-4 is critically involved in the regulation of the human immune response to allogeneic grafts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299026      PMCID: PMC1856219          DOI: 10.1136/gut.2005.080937

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells.

Authors:  G Magistrelli; P Jeannin; N Herbault; A Benoit De Coignac; J F Gauchat; J Y Bonnefoy; Y Delneste
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

3.  A native soluble form of CTLA-4.

Authors:  M K Oaks; K M Hallett; R T Penwell; E C Stauber; S J Warren; A J Tector
Journal:  Cell Immunol       Date:  2000-05-01       Impact factor: 4.868

Review 4.  Is CTLA-4 a master switch for peripheral T cell tolerance?

Authors:  J A Bluestone
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

Review 5.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.

Authors:  B Salomon; J A Bluestone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

6.  CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

Authors:  S Fecteau; G P Basadonna; A Freitas; C Ariyan; M H Sayegh; D M Rothstein
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

7.  Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease.

Authors:  M K Oaks; K M Hallett
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

8.  Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection.

Authors:  E Slavcheva; E Albanis; Q Jiao; H Tran; C Bodian; R Knight; E Milford; T Schiano; Y Tomer; B Murphy
Journal:  Transplantation       Date:  2001-09-15       Impact factor: 4.939

9.  CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis.

Authors:  K Agarwal; D E Jones; A K Daly; O F James; B Vaidya; S Pearce; M F Bassendine
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

10.  CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Authors:  T Kouki; Y Sawai; C A Gardine; M E Fisfalen; M L Alegre; L J DeGroot
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

View more
  12 in total

1.  Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.

Authors:  Cheng-Lin Zhu; Qiang Huang; Chen-Hai Liu; Fang Xie
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

Review 2.  Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors:  J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Influence of glutathione S-transferase M1 and T1 polymorphisms with acute rejection in Iranian liver transplant recipients.

Authors:  Negar Azarpira; Saman Nikeghbalian; Bita Geramizadeh; Masumeh Darai
Journal:  Mol Biol Rep       Date:  2009-02-28       Impact factor: 2.316

4.  CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients.

Authors:  Yifeng Guo; Fang Guo; Chongyang Wei; Jianxin Qiu; Yong Liu; Yu Fang; Junwei Gao
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  CTLA4 polymorphisms and de novo malignancy risk after renal transplantation in Chinese recipients.

Authors:  Yi-feng Guo; Jian-xin Qiu; Fang Guo; Yong Liu; Ming-hua Shang
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

6.  Association of GSTO2 (N142D) Genetic Polymorphism and Acute Rejection of Liver.

Authors:  M Khosravi; I Saadat; M H Karimi; S A Malek Hosseini
Journal:  Int J Organ Transplant Med       Date:  2016-08-01

7.  HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Authors:  Bjarte Fosby; Sigrid Næss; Johannes R Hov; James Traherne; Kirsten M Boberg; John Trowsdale; Aksel Foss; Pål-Dag Line; Andre Franke; Espen Melum; Helge Scott; Tom H Karlsen
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

8.  Recipient cytotoxic T lymphocyte antigen 4 +49 single-nucleotide polymorphism is not associated with acute rejection after liver transplantation in Chinese population.

Authors:  Zhijun Jiang; Ying Chen; Xiaonin Feng; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Int J Med Sci       Date:  2013-01-22       Impact factor: 3.738

9.  Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients.

Authors:  Yifeng Guo; Yu Fan; Jianxin Qiu; Yong Liu; Junwei Gao; Fang Guo
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort.

Authors:  Tammy M Martin; Louise Bye; Neil Modi; Miles R Stanford; Robert Vaughan; Justine R Smith; N Kevin Wade; Friederike Mackensen; Eric B Suhler; James T Rosenbaum; Graham R Wallace
Journal:  Mol Vis       Date:  2009-01-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.